HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)

Detalles Bibliográficos
Autores principales: Baran, RW, Dietz, B, Fredrick, LM, Tian, M, Podsadecki, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113086/
http://dx.doi.org/10.1186/1758-2652-13-S4-P8
_version_ 1782205884733063168
author Baran, RW
Dietz, B
Fredrick, LM
Tian, M
Podsadecki, T
author_facet Baran, RW
Dietz, B
Fredrick, LM
Tian, M
Podsadecki, T
author_sort Baran, RW
collection PubMed
description
format Online
Article
Text
id pubmed-3113086
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130862011-06-13 HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC) Baran, RW Dietz, B Fredrick, LM Tian, M Podsadecki, T J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113086/ http://dx.doi.org/10.1186/1758-2652-13-S4-P8 Text en Copyright ©2010 Baran et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Baran, RW
Dietz, B
Fredrick, LM
Tian, M
Podsadecki, T
HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
title HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
title_full HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
title_fullStr HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
title_full_unstemmed HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
title_short HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
title_sort hrqol improves in treatment-naïve hiv-1 subjects initiated on lopinavir/ritonavir (lpv/r) with raltegravir (ral) or tenofovir/emtricitabine (tdf/ftc)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113086/
http://dx.doi.org/10.1186/1758-2652-13-S4-P8
work_keys_str_mv AT baranrw hrqolimprovesintreatmentnaivehiv1subjectsinitiatedonlopinavirritonavirlpvrwithraltegravirralortenofoviremtricitabinetdfftc
AT dietzb hrqolimprovesintreatmentnaivehiv1subjectsinitiatedonlopinavirritonavirlpvrwithraltegravirralortenofoviremtricitabinetdfftc
AT fredricklm hrqolimprovesintreatmentnaivehiv1subjectsinitiatedonlopinavirritonavirlpvrwithraltegravirralortenofoviremtricitabinetdfftc
AT tianm hrqolimprovesintreatmentnaivehiv1subjectsinitiatedonlopinavirritonavirlpvrwithraltegravirralortenofoviremtricitabinetdfftc
AT podsadeckit hrqolimprovesintreatmentnaivehiv1subjectsinitiatedonlopinavirritonavirlpvrwithraltegravirralortenofoviremtricitabinetdfftc

Ejemplares similares